Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2024 Financial Results on August 8, 2024

Company Overview - Organogenesis Holdings Inc. is a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical & Sports Medicine markets [3]. Financial Results Announcement - The company will report its second quarter of fiscal year 2024 financial results after the market closes on Thursday, August 8th [1]. - A conference call will be hosted by management at 5:00 p.m. Eastern Time on August 8th to discuss the quarterly results and provide a corporate update, including a question and answer session [2]. Access Information - Participants can access the live webcast through the provided link or by dialing (800) 715-9871 with access code 6679912 [2]. - The live webcast will also be available on the company's website and archived for approximately one year [2].